Identification and utility exploration of a highly potent and long acting bullfrog GLP 1 analogue in GLP 1 and amylin combination therapy ScienceDirect CagriSema Dual Pathway Metabolic Signaling Compound CagriSema combines two investigational molecules Cagrilintide (amylin analogue) and Semaglutide ( GLP 1 receptor agonist), designed to influence key metabolic and appetite regulating pathways. Current Cagrilintide Lumin Peptides BPC 157 Pure Oral Spray, Integrative Peptides Professional Supplement Center BPC 157 Peptide Therapy Advanced Healing & Regeneration